Dry eye after photorefractive keratectomy (PRK) and transepithelial photorefractive keratectomy (T-PRK): a comparative clinical study
- PMID: 40540100
- DOI: 10.1007/s10792-025-03626-y
Dry eye after photorefractive keratectomy (PRK) and transepithelial photorefractive keratectomy (T-PRK): a comparative clinical study
Abstract
Purpose: To compare dry eye disease (DED) following PRK and T-PRK surgeries using a combined approach of subjective and objective measures, focusing on clinically meaningful outcomes and adjusted statistical modeling.
Methods: In this prospective observational study, 89 eyes of patients aged over 20 years were enrolled and grouped into PRK (43 eyes) and T-PRK (46 eyes). The primary outcome was change in ocular surface diseases index (OSDI) score at 6 months. Secondary outcomes included non-invasive tear breakup time (NITBUT) and meibomian gland expressibility. Exploratory parameters such as tear meniscus height (TMH), redness score, strip meniscometry (SM Tube), meibomian gland dropout, and meibum quality were also assessed. Statistical models were adjusted for baseline age differences, and corrections for multiple comparisons were applied.
Results: The mean age of the patients was 34.16 ± 7.23 in the PRK and 28.72 ± 6.26 in the T-PRK group (P < 0.001). The two groups were not significantly different for gender (P = 0.367). After statistical adjustment, only the change in OSDI and NITBUT at 1-month remained significant between groups (adjusted P = 0.038 and P < 0.05, respectively). Effect sizes were small to moderate, and none of the differences exceeded minimal clinically important thresholds. Exploratory analyses revealed no significant between-groups differences. Age was identified as an independent predictor of OSDI change.
Conclusion: In short-term follow-up, both procedures induced some degree of DED. However, T-PRK was associated with slightly fewer signs and symptoms of dry eye disease, but the differences were not clinically significant.
Keywords: Dry eye; Photorefractive keratectomy; Refractive surgery; Transepithelial photorefractive keratectomy.
© 2025. The Author(s), under exclusive licence to Springer Nature B.V.
Conflict of interest statement
Declarations. Conflicts of interest: The authors have not disclosed any conflicts of interests. Consent to participate: Written informed consent was obtained from participants included in the study. Consent for publication: Not applicable. Ethics approval: The study protocol adhered to the tenets of the Declaration of Helsinki and was approved by the ethics committee of Mashhad University of Medical Sciences (Ethical code: IR.MUMS.FHMPM.REC.1400.003). Written informed consent was obtained from all participants before the study.
Similar articles
-
Laser-assisted subepithelial keratectomy (LASEK) versus photorefractive keratectomy (PRK) for correction of myopia.Cochrane Database Syst Rev. 2016 Feb 22;2(2):CD009799. doi: 10.1002/14651858.CD009799.pub2. Cochrane Database Syst Rev. 2016. PMID: 26899152 Free PMC article.
-
Laser-assisted subepithelial keratectomy (LASEK) versus laser-assisted in-situ keratomileusis (LASIK) for correcting myopia.Cochrane Database Syst Rev. 2017 Feb 15;2(2):CD011080. doi: 10.1002/14651858.CD011080.pub2. Cochrane Database Syst Rev. 2017. PMID: 28197998 Free PMC article.
-
Photorefractive keratectomy with extended ablation zone for recurrent corneal erosion syndrome accompanied with refractive errors: a study of effectiveness, safety, and refractive outcomes.Front Med (Lausanne). 2025 Jul 18;12:1592539. doi: 10.3389/fmed.2025.1592539. eCollection 2025. Front Med (Lausanne). 2025. PMID: 40757202 Free PMC article.
-
Effects of Lotrafilcon A and Senofilcon A Bandage Contact Lenses on Visual Outcome and Ocular Comfort After Photorefractive Keratectomy.Turk J Ophthalmol. 2024 Dec 31;54(6):318-323. doi: 10.4274/tjo.galenos.2024.03392. Turk J Ophthalmol. 2024. PMID: 39743926 Free PMC article.
-
Impact of epithelial removal techniques on low contrast acuity after photorefractive keratectomy: A prospective randomized study.J Fr Ophtalmol. 2025 Jun;48(6):104514. doi: 10.1016/j.jfo.2025.104514. Epub 2025 Apr 11. J Fr Ophtalmol. 2025. PMID: 40215757 Clinical Trial.
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical